MiRagen Therapeutics Receives $8,499,962 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c5a7fc7f-bc54-43da-be19-4b50a471324b - Date
2/18/2015 - Company Name
MiRagen Therapeutics - Mailing Address
6200 Lookout Rd Boulder, CO 80301 USA - Company Description
Miragen was founded in 2007 to exploit recent discoveries showing that specific perturbations in microRNA expression are correlated with various forms of cardiovascular disease. - Website
http://www.miragentherapeutics.com - Transaction Type
Debt - Transaction Amount
$8,499,962 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
